US EditionMinnesota study backs birth vaccine for hepatitis B
A review of over 400 studies finds the birth dose prevents infections with a 95% drop in pediatric hepatitis B cases since 1991, supporting continued universal vaccination.
- On Tuesday, the University of Minnesota-led CIDRAP Vaccine Integrity Project urged federal health advisers to maintain the universal hepatitis B birth dose, saying elimination does not improve outcomes.
- ACIP members face renewed debate as the committee postponed a September vote on delaying the birth dose for infants of hepatitis B–negative mothers and will revisit it at the Dec. 4 meeting, after Robert F. Kennedy Jr., Health Secretary, appointed members with vaccine-safety concerns.
- Examining more than 400 studies, researchers determined the CIDRAP Vaccine Integrity Project found the birth dose safe and effective, with current guidance giving the first hepatitis B dose within 24 hours of birth supported by federal advisers.
- The report notes major public-health gains, finding the current vaccination strategy has prevented more than 6 million infections and nearly 1 million hepatitis B-related hospitalizations.
- The authors noted safety data showing only mild complications, with no severe adverse reactions or deaths, according to CIDRAP Director Michael Osterholm, who warned `the real question before ACIP is whether its members will vote based on the evidence`.
12 Articles
12 Articles
Delaying Hep B Vaccine in Infants Carries Significant Risks, Report Warns
(MedPage Today) -- A comprehensive review of hepatitis B vaccination found no evidence that delaying the birth dose provides any safety or efficacy benefits and identified substantial risks associated with changing long-standing recommendations...
Times of India
The Economic TimesEvidence confirms U.S. newborn Hepatitis B vaccination policy amid calls to delay
An independent review of more than 400 studies confirms that the U.S. policy of providing the hepatitis B vaccine to newborns has reduced childhood infections by over 95%. Since its 1991 implementation, the birth-dose approach has prevented more than 6 million infections and almost 1 million hospitalizations. The CDCs advisory panel, recently reorganized by health secretary Robert F. Kennedy Jr., will vote on the policy this week.
University of Minnesota researchers say hepatitis B vaccine safe for babies, despite federal concern
A report from the University of Minnesota’s Vaccine Integrity Project maintains the recommendation for newborn hepatitis B vaccination. This contradicts arguments from Trump administration health advisors like Robert F. Kennedy, Jr. who may recommend a vaccine delay later this month.
University of Minnesota project backs hepatitis B vaccine, challenges Trump administration
A University of Minnesota-led review is urging federal health advisers to maintain a longstanding immunization strategy that has hepatitis B on the verge of elimination in the U.S. Offering vaccinations within 24 hours of birth is a safe and ...
Coverage Details
Bias Distribution
- 64% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
